Lipoprotein(a)

detranslation pending

Lipoprotein(a): Ärzte waren sicher: Das wird ein Durchbruch in der Herzmedizin

Zeit Gesundheit · 11h ago

Experimental heart drug reduces Lp(a) levels, but fails to impact outcomes—what went wrong?

Cardiovascular Business · 1d ago

study

Where Next for Lp(a)?

JAMA Internal Medicine · 2d ago

de

Pelacarsen lowers Lp(a) sharply but prevents no cardiovascular eventsPelacarsen senkt Lp(a) deutlich, verhindert aber keine kardiovaskulären Ereignisse

Deutsches Ärzteblatt · 2d ago

de

“The importance of Lp(a) apparently falls sharply when other risk factors are very well controlled”„Die Bedeutung von Lp(a) nimmt bei sehr guter Kontrolle der übrigen Risikofaktoren offenbar deutlich ab“

Deutsches Ärzteblatt · 2d ago

sv

Big disappointment for a hyped treatment principleStor besvikelse för upphaussad behandlingsprincip

Läkemedelsvärlden · 2d ago

ja

Lp(a)-lowering drug pelacarsen fails to reduce cardiovascular riskLp(a)低下薬pelacarsen、心血管リスク抑制せず

日経メディカル · 2d ago

Lp(a) - talk about stone cold negative

Sensible Medicine · 2d ago

L-Carnitine vs Lp(a); HbA1c vs Coronary Artery Inflammation

Reddit r/longevity · 3d ago

detranslation pending

Rückschläge im Kampf gegen Herz-Kreislauf-Erkrankungen: Zwei vielversprechende Medikamente erweisen sich als nutzlos

NZZ Wissenschaft · 3d ago

Lp(a)-Lowering Pelacarsen Shows Huge Disconnect With Cardiovascular Outcomes

MedPage Today · 4d ago

Pelacarsen does not reduce CV events in patients with high Lp(a)

Healio · 4d ago

studyobservational

Elevated Lipoprotein(a) Linked to Recurrent Heart Attack Risk

EMJ Reviews · 4d ago

study

STAT+: Failure of Novartis Lp(a) drug raises questions about cardiovascular strategy

STAT News · 4d ago

study

Lp(a) HORIZON trial: Lp(a) fell by 78%, but cardiovascular outcomes unexpectedly neutral

AHA Newsroom · 4d ago

es

Hard blow to lipoprotein(a) research: lowering it does not prevent cardiovascular riskDuro revés a la investigación frente a la lipoproteína (a): su reducción no evita el riesgo de sufrir problemas cardiovasculares

El Mundo Salud · 4d ago

study

Pelacarsen and Cardiovascular Outcomes in Patients with High Lipoprotein(a)

NEJM · 4d ago

studyobservational

Analysis of reproductive traits associated with lipoprotein(a) deficiency in participants from the Pakistan Genome Resource

bioRxiv - Genetics · 6d ago

study

This cholesterol drug promised to be a game-changer. Why did it flop in the clinic — and is there still hope?

Nature News · 9d ago

The Wonders of Modern Medicine

Reddit r/Biohackers · 11d ago

study

Lipoprotein(a) and Risk Stratification for Atherosclerotic Cardiovascular Disease Across the Cardiovascular‐Kidney‐Metabolic Continuum

JAHA · 19d ago

study

Pelacarsen and Lp(a)HORIZON: Interpreting the Disconnect Between Lipoprotein(a) Lowering and Cardiovascular Outcomes

The American Journal of Medicine · 28d ago

study

Lipoprotein(a) and Incident Aortic Stenosis Over 30 Years: The ARIC Study

ATVB · 48d ago

Marios Georgakis: Why Did Two Major Clinical Trials for Heart Disease Fail?

Ground Truths (Eric Topol) · 58d ago

The Coronary Artery Inflammation Controversy

Ground Truths (Eric Topol) · 67d ago

podcast

From Cocaine Dealing & Prison Workouts To The #1 Health Podcast In The World, With Dylan Gemelli

Ben Greenfield Life (podcast) · 88d ago

study

Predictive Value of Lipoprotein(a) and LPA Genetic Risk Score for Incident of Sudden Cardiac Death

Mayo Clinic Proceedings · 113d ago

podcast

How Heart Care Has Changed in the Last 20 Years (3 Cardiologists Explain) – Part 1

The Healthy Skeptic · 213d ago

Sources

Coverage